What is the treatment for fat embolism syndrome (FES)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Fat embolism syndrome treatment should prioritize early definitive osteosynthesis of long-bone fractures to prevent ARDS and fat embolism syndrome, as recommended in the most recent guidelines 1.

Key Considerations

  • The primary goal is to prevent further complications such as ARDS and fat embolism syndrome by stabilizing the fracture early on.
  • In patients who are haemodynamically unstable or have severe preoperative respiratory compromise, a multidisciplinary discussion is necessary to weigh the benefits and risks of definitive osteosynthesis versus external fixation 1.
  • Supportive care, including respiratory support with supplemental oxygen and fluid resuscitation, is crucial in managing fat embolism syndrome.
  • The use of corticosteroids, such as methylprednisolone, is controversial and should be approached with caution due to potential detrimental effects in certain patient populations 1.

Management Strategies

  • Early immobilization of fractures to prevent additional fat from entering the circulation.
  • Continuous monitoring of vital signs, arterial blood gases, and neurological status.
  • Pain management with appropriate analgesics.
  • Prophylactic anticoagulation with low molecular weight heparin to prevent deep vein thrombosis.

Decision Making

  • The decision to perform definitive osteosynthesis or external fixation should be made on a case-by-case basis, considering the patient's overall condition and the potential risks and benefits of each approach 1.
  • The most recent guidelines should be consulted to ensure that treatment is aligned with current best practices 1.

From the Research

Fat Embolism Syndrome Treatment

  • The treatment of fat embolism syndrome (FES) primarily focuses on supportive care, including oxygen therapy, fluid management, and hemodynamic stabilization 2, 3.
  • In severe cases, advanced life support such as extracorporeal membrane oxygenation (ECMO) may be required to manage refractory hypoxemia and hemodynamic instability 4.
  • Early supportive pulmonary therapy and other resuscitative measures may halt the pathophysiologic cascade and prevent clinical deterioration 2.
  • Medical care is prophylactic or supportive, including early fixation and general ICU management to ensure adequate oxygenation and ventilation, hemodynamic stability, prophylaxis of deep venous thrombosis, stress-related gastrointestinal bleeding, and nutrition 5.
  • The main therapeutic interventions once FES has been clinically diagnosed are directed towards support of pulmonary and neurological manifestations and management of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) 5.
  • Corticosteroids may be used in the treatment of FES, although their role remains controversial 3, 6.
  • Early stabilization of long bone fractures has been shown to decrease the incidence of pulmonary complications 3.

Specific Treatment Approaches

  • ECMO has been shown to be a crucial bridge to recovery for patients with FES who do not respond to conventional therapies 4.
  • High-dose corticosteroid and sivelestat sodium may be effective in treating FES, as seen in a case report of a 78-year-old woman with acute chronic respiratory failure due to FES 6.
  • Mechanical ventilation may be indicated in cases of respiratory failure due to FES 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Fat embolism syndrome.

American journal of orthopedics (Belle Mead, N.J.), 2002

Research

Fat embolism syndrome.

Canadian journal of surgery. Journal canadien de chirurgie, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.